Cardinal Health’s stock price closed at $148.22 USD on May 7, 2025, with a 52-week high of $154.07 USD and a 52-week low of $93.17 USD on July 14, 2024.
Cardinal Health’s stock performance is expected to benefit from the growing home healthcare market, driven by factors such as cost efficiency and improved patient outcomes.
Cardinal Health’s stock price has surged 46.5% over the past year, but its revenue growth is offset by declining net income, leaving investors uncertain about its long-term sustainability.
Cardinal Health’s stock has declined due to mixed signals from top research firms, but its potential to contribute to the healthcare industry’s growth remains a significant factor in its favor.
Cardinal Health’s stock price has reached a 52-week high, driven by optimism about the company’s prospects in the rapidly growing pediatric interventional cardiology market.